Jing Zhao

机构：Hebei Medical University, Lee's Pharmaceutical (China) · ORCID：0000-0002-6566-599X

发表论文 1026 篇 · 总被引 7618 次 · h-index 26

代表论文

• A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma (2025 · Blood · 被引 21)
• A new yeast-based bioreporter for simple, sensitive, and cost-effective detection of dioxin-like compounds (2024 · Sensors and Actuators B Chemical · 被引 12)
• Randomized controlled trial investigating the effect of a Baduanjin exercise plus nutrition programme on cancer-related fatigue in elderly lung cancer patients receiving chemotherapy (2025 · Experimental Gerontology · 被引 11)
• Vaginal microbiome and sexually-transmitted pathogens in Chinese reproductive-age women: a multicentre cross-sectional and longitudinal cohort study (2025 · Nature Communications · 被引 9)
• The safety, tolerability, pharmacokinetics and pharmacodynamics of GZR18 in healthy American and Chinese adult subjects (2025 · Diabetes Obesity and Metabolism · 被引 7)
• Effect of Yishenqinglihuoxue formula in the treatment of patients with stage 5 chronic kidney disease using propensity score matching: A retrospective clinical study (2025 · Clinical Traditional Medicine and Pharmacology · 被引 6)